Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.
about
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical TrialsAlternative Donor Transplantation for Acute Myeloid LeukemiaUmbilical cord blood transplantation for the treatment of hematologic malignanciesSingle-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.A preclinical model of double- versus single-unit unrelated cord blood transplantation.Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.Double unrelated reduced-intensity umbilical cord blood transplantation in adults.Evaluation of Quality Parameters for Cord Blood Donations.Concise review: umbilical cord blood transplantation: past, present, and futureImmune Reactions following Cord Blood Transplantations in Adults.A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.Hematopoietic stem cell transplantation in children with leukemia: a single institution experience with respect to donors.Scientific and clinical opportunities for modeling blood disorders with embryonic stem cellsAnalysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.Insights and hopes in umbilical cord blood stem cell transplantationsCord blood transplantation for adults.Expanding the role of umbilical cord blood transplantation.Unrelated umbilical cord blood transplantation and immune reconstitution.Searching for alternative hematopoietic stem cell donors for pediatric patients.Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.Unrelated hematopoietic stem cell transplantation for children with acute leukemia: experience at a single institution.Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.Pediatric related and unrelated cord blood transplantation for malignant diseases.Future of cord blood for oncology uses.An overview of the progress on double umbilical cord blood transplantation.Blood stem cell products: toward sustainable benchmarks for clinical translation.T cell depletion in paediatric stem cell transplantation.The current role of T cell depletion in paediatric stem cell transplantation.Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial.National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States.Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances.Allogeneic cord blood transplantation in children with hematological malignancies: a long-term follow-up single-center study.Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database.Analysis of risk factors of cord blood transplantation for children.Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan.Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China.Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.
P2860
Q26772216-E8EB88A5-DBB9-4644-BB4B-F25C316C3F6FQ26799456-D6971CC4-A508-456C-9667-7374323BEDCFQ26820829-C123F824-2602-40B9-B67E-C477F50B038DQ33627040-BFD0FF99-0DD5-412B-B802-20CB06396109Q33965521-DE1E0239-03A8-4545-8E67-E8B4E02B15FCQ34049208-E0C03199-A971-4AA2-8F07-2A5A6886B515Q34162647-045475CD-BB9B-486F-863F-B0A609E657BCQ34263554-F0A0EE5C-1BB9-4180-8A97-5F296C14328DQ34601968-116A9C96-468A-401A-AF15-53003FD59387Q35054475-0C620D0E-8E7B-40EE-936A-CE4B9DA75E99Q35285087-24BE8FB6-6C4F-4868-9369-5AFB4DBB689EQ35590604-0BC6F1BE-4D28-4726-B3C2-4D8DC25B7739Q35848553-75ADBC20-F6DB-4AD2-8A6A-6DC2A6FA2C92Q36002278-6F63C3AF-15DE-4C8F-8479-E38184CC7CBBQ36432837-C64690BD-4311-467D-A62F-436524CAFB95Q36588337-4E735E64-0CFD-4AD6-8850-835FFEC6D91EQ36759585-34C98240-D334-40A8-8990-2D054533E259Q36934304-4F6CC196-8B0D-4921-B02E-0499422242D9Q37033846-0469EF18-FFDE-4369-9C1B-DB78E7647484Q37129657-5C2F2094-D99E-447A-A163-8704C71527BDQ37131658-16899AEF-50BD-4C8E-A115-B9366FB677BFQ37364550-EAF88D31-A05F-42D0-A4DA-171A96AD2FD5Q37414733-77D38E7E-0CF2-4C0F-A66C-71D6109CDD85Q37607974-8E06441E-FE7B-477B-AB8E-DE1AD2EDD3FAQ37607977-522321CE-4397-402F-92B1-5CD07B296219Q37872506-90BB2962-2ED8-4EE5-AF32-EA7B50CAF235Q38072649-7A52271B-295E-4BEF-8242-BAF7A1DF1374Q38097916-191F428C-EED3-401B-AA95-ADF9B5737078Q38110308-CD586F22-9793-4CDB-A4A0-EE0D27364EEFQ39877306-8F57DE9B-2E75-4D06-A0D6-A029B8C856E8Q40408382-BFD9898B-522E-4878-8A8C-D1B48669FEF8Q43481632-24CE5181-B86E-4136-ACF8-3EB8EFE3DEF7Q43602281-D3E696B0-741E-4BBF-BD88-049505C8A62CQ44756831-6530F6C1-4919-4A4F-9202-D0F97F5922DAQ45138725-23A7FF23-286A-4A69-A0B8-0928CD428BACQ46910457-BBFD2794-B64F-4F13-8FD0-8EC6BF2604CEQ51867494-1E0BA191-EA40-4BE9-86A9-087980EC9524Q52613271-454CE8CD-7D9D-4C85-8F29-78A5A5981C9BQ53533468-3EC2A446-E78B-4790-81D9-E09034AB35A2Q54310310-6183FFCA-E22E-46FC-9231-BF4C24BFA654
P2860
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Unrelated cord blood transplan ...... ia: a Eurocord Group analysis.
@ast
Unrelated cord blood transplan ...... ia: a Eurocord Group analysis.
@en
type
label
Unrelated cord blood transplan ...... ia: a Eurocord Group analysis.
@ast
Unrelated cord blood transplan ...... ia: a Eurocord Group analysis.
@en
prefLabel
Unrelated cord blood transplan ...... ia: a Eurocord Group analysis.
@ast
Unrelated cord blood transplan ...... ia: a Eurocord Group analysis.
@en
P2093
P50
P1433
P1476
Unrelated cord blood transplan ...... ia: a Eurocord Group analysis.
@en
P2093
Alexandra Filipovich
Alexandra Machado
Amparo Verdeguer
Anna Paola Iori
Blanca Diez
Chiara Messina
Eric Sievers
Euripedes Ferreira
Eurocord Group
Federico Garnier
P304
P356
10.1182/BLOOD-2003-04-1288
P407
P577
2003-08-14T00:00:00Z